Teleflex orporated
Open
$124.40
Prev. Close
$124.35
High
$124.40
Low
$124.40
Market Snapshot
$5.89B
-6.5
1.45
$2.69B
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
emptyResult
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Recently from Cashu
Teleflex Under Pressure to Improve Shareholder Engagement Amid Growing Investor Demands
Teleflex Under Pressure to Enhance Shareholder Engagement Teleflex Incorporated finds itself at a crucial juncture as Irenic Capital, a shareholder with a 2% stake in the company, advocates for increa…
Teleflex Navigates Mixed Analyst Sentiment Amidst Healthcare Technology Challenges and Opportunities
Teleflex’s Evolving Landscape in Medical Technology Teleflex Incorporated continues to navigate a complex and competitive landscape in the medical technology sector, a realm underscored by both opport…
Teleflex Inc. Reports Q4 Revenue Growth Driven by Innovation and Strategic Initiatives
Teleflex's Q4 Performance Reflects Strategic Growth in Medical Technology Teleflex Incorporated announces its fourth-quarter earnings results for fiscal year 2026, showcasing a revenue of $620 million…
Teleflex's Innovation Drives 5% Revenue Growth and Optimistic Outlook for Fiscal 2027
### Teleflex's Strategic Innovation Fuels Growth in Medical Technology Teleflex Incorporated reports a solid performance in its fourth-quarter earnings for 2026, with revenues reaching $620 million, r…